0
0
12/28/22 at 4:27am
Organization
Abplive.com
Author
ABP News Bureau
37 words
0
Comments
The government on Friday approved Bharat Biotech's intranasal vaccine, iNCOVACC as a booster dose for those aged 18 years and above.
You are the first to view
https://news.abplive.com/news/india/nasal-vaccine-not-recommended-after-precaution-dose-says-covid-task-force-chief-report-1572210
Create an account
or login to join the discussion